advertisement
11.14 Investigational drugs; pharmacological experiments (40)
Showing records 1 to 25
Display all abstracts in classification 11.14 Investigational drugs; pharmacological experiments
Search within classification 11.14 Investigational drugs; pharmacological experiments80056 Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension
Fingeret M
Clinical and Experimental Optometry 2019; 102: 541-550
79820 Anti-scarring effect of rapamycin in rabbits following glaucoma filtering surgery
Kang X
Journal of Southern Medical University 2018; 38: 1389-1394
79787 Evidence on neuroprotective properties of coenzyme Q10 in the treatment of glaucoma
Martucci A
Neural Regeneration Research 2019; 14: 197-200
79961 Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)
Kahook MY
American Journal of Ophthalmology 2019; 200: 130-137
79411 RKI-1447, a Rho kinase inhibitor, causes ocular hypotension, actin stress fiber disruption, and increased phagocytosis
Dang Y
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 101-109
79521 Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma
Hu C
Advanced healthcare materials 2018; 7: e1801047
79713 Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma
Lin C
Eye 2019; 33: 777-784
79393 Omidenepag Isopropyl Ophthalmic Solution 0.002%: First Global Approval
Duggan S
Drugs 2018; 78: 1925-1929
79820 Anti-scarring effect of rapamycin in rabbits following glaucoma filtering surgery
Shen Y
Journal of Southern Medical University 2018; 38: 1389-1394
79961 Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)
Serle JB
American Journal of Ophthalmology 2019; 200: 130-137
79411 RKI-1447, a Rho kinase inhibitor, causes ocular hypotension, actin stress fiber disruption, and increased phagocytosis
Wang C
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 101-109
79521 Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma
Sun J
Advanced healthcare materials 2018; 7: e1801047
79713 Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma
Wu F
Eye 2019; 33: 777-784
79787 Evidence on neuroprotective properties of coenzyme Q10 in the treatment of glaucoma
Nucci C
Neural Regeneration Research 2019; 14: 197-200
80056 Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension
Gaddie IB
Clinical and Experimental Optometry 2019; 102: 541-550
79820 Anti-scarring effect of rapamycin in rabbits following glaucoma filtering surgery
Zhao H
Journal of Southern Medical University 2018; 38: 1389-1394
80056 Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension
Bloomenstein M
Clinical and Experimental Optometry 2019; 102: 541-550
79713 Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma
Zheng T
Eye 2019; 33: 777-784
79521 Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma
Zhang Y
Advanced healthcare materials 2018; 7: e1801047
79961 Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)
Mah FS
American Journal of Ophthalmology 2019; 200: 130-137
79411 RKI-1447, a Rho kinase inhibitor, causes ocular hypotension, actin stress fiber disruption, and increased phagocytosis
Shah P; Waxman S
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 101-109
79713 Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma
Wang X
Eye 2019; 33: 777-784
79961 Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)
Kim T
American Journal of Ophthalmology 2019; 200: 130-137
79820 Anti-scarring effect of rapamycin in rabbits following glaucoma filtering surgery
Wang Z
Journal of Southern Medical University 2018; 38: 1389-1394
79521 Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma
Chen J; Lei Y
Advanced healthcare materials 2018; 7: e1801047
